The European Medicines Agency review of ipilimumab (Yervoy) for the treatment of advanced (unresectable or metastatic) melanoma in adults who have received prior therapy: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use

Bibliographic Details
Title: The European Medicines Agency review of ipilimumab (Yervoy) for the treatment of advanced (unresectable or metastatic) melanoma in adults who have received prior therapy: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use
Authors: Hanaizi, Z., van Zwieten-Boot, B., Calvo, G., Lopez, A. S., van Dartel, M., Camarero, J., Abadie, E., Pignatti, F.
Source: EUROPEAN JOURNAL OF CANCER. 48(2):237-242
Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN304373815&indx=1&recIds=ETOCRN304373815
Database: British Library Document Supply Centre Inside Serials & Conference Proceedings
More Details
ISSN:09598049
Published in:EUROPEAN JOURNAL OF CANCER
Language:English